DOCSLIB.ORG

(2) Patent Application Publication (10) Pub. No.: US 2015/0094266 A1 Di Fulvio Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(2) Patent Application Publication (10) Pub. No.: US 2015/0094266 A1 Di Fulvio Et Al US 201500.94266A1 (19) United States (2) Patent Application Publication (10) Pub. No.: US 2015/0094266 A1 Di Fulvio et al. (43) Pub. Date: Apr. 2, 2015 (54) XYLOGLUCAN AND PROTEIN (30) Foreign Application Priority Data COMPOSITIONS FOR THE TREATMENT OF INTESTINAL DISORDERS Jun. 11, 2013 (IT) .......................... MI2013A000.960 Apr. 15, 2014 (IT) .......................... MI2014AO00705 (71) Applicant: Novintethical Pharma, SA, Lugano Publication Classification (CH) (51) Int. Cl. (72) Inventors: Marco Di Fulvio, Soriano nel Cimino A61 K 38/39 (2006.01) (IT); Miguel Angel Alonso, Barcelona A61 K 38/16 (2006.01) (ES); Michele Giuseppe Di Schiena, 4. #% § Robecco sul Naviglio (IT) A61 K 45/06 (2006 oil (52) U.S. CI. (73) Assignee:- - Sºmee e Pharma, SA, Lugano CPC ...............(2013.01); A61K 38/39 A61K (2013.01); 45/06 (2013.01); A61K3I/716 A61 K (CH) 31/732 (2013.01); A61K 38/168 (2013.01) USPC ......................... 514/13.2; 514/17.2, 514/21.2 (21) Appl. No.: 14/566,546 (57) ABSTRACT Compositions include synergistic combinations of xyloglu cans and vegetable or animal proteins that are useful in the (22) Filed: Dec. 10, 2014 treatment of intestinal disorders or of disorders originating from the intestinal system and transferred to other systems, such as the genitourinary system. The compositions include Related U.S. Application Data xyloglucans or an extract containing xyloglucans, and one or more animal or vegetable proteins. Methods for the treatment (63) Continuation-in-part of application No. 14/092,365, or prevention of intestinal disorders are provided, including filed on Nov. 27, 2013. prevention of diarrhoea. Patent Application Publication Apr. 2, 2015 Sheet 1 of 2 US 2015/0094.266 A1 FIG. I. Patent Application Publication Apr. 2, 2015 Sheet 2 of 2 US 2015/0094.266 A1 *: p-0.001 from vehicle #: p-0.05 from CT CT FIG. 2 US 2015/0094.266 A1 Apr. 2, 2015 XYLOGLUCAN AND PROTEIN [0011] A composition for use in the prevention and treat COMPOSITIONS FOR THE TREATMENT OF ment of intestinal disorders or of disorders originating in the INTESTINAL DISORDERS intestinal system and transferred to other systems, is pro vided, said composition containing xyloglucans or extracts CROSS-REFERENCE TO RELATED containing xyloglucans, and at least one animal or vegetable APPLICATIONS protein. One preferred protein is gelatin. [0001] This is a continuation-in-part of co-pending U.S. [0012] A method for prevention or treatment of intestinal application Ser. No. 14/092,365, filed Nov. 27, 2013, which disorders or of disorders originating in the intestinal system claims priority to Italian Application No. MI2013A000960, and transferred to other systems, is provided, said method filed Jun. 11, 2013. The present application also claims pri comprising the steps of providing a composition comprising ority to Italian Application No. MI2014AO00705, filed Apr. xyloglucans or extracts containing xyloglucans, and at least 15, 2014. Each of the foregoing applications are hereby incor one animal or vegetable protein; and administering an effec porated by reference herein in their entirety. tive amount of the composition to a mammal in need thereof, said mammal having an intestinal disorder or a disorder origi FIELD OF THE INVENTION nating in the gastro-intestinal system and transferred to other systems. [0002] The invention refers to combinations that include [0013] In a further embodiment, a method for the preven synergistic combinations of xyloglucans and animal or veg tion of diarrhoea is provided, comprising the steps of pro etable proteins and to compositions for the treatment of intes viding a composition comprising xyloglucans or extracts tinal disorders, in particular diarrhoeal diseases of various containing xyloglucans, and a gelatin; and orally administer origin. ing an effective amount of the composition to a mammal in need thereof, whereby diarrhoea, or symptoms thereof, are BACKGROUND prevented. [0003] Diarrhoea is an often debilitating and dangerous symptom of many gastrointestinal disorders, especially in BRIEF DESCRIPTION OF THE DRAWINGS children and the elderly. Acute diarrhoea is primarily caused by intestinal infections, but may also be due to the use of [0014] FIG. 1 depicts the difference in water secretion in drugs, to radiation treatments and to other pathological con isolated intestinal jejunal loops 2 hrs after cholera toxin (CT) ditions (diverticulitis, poisoning by heavy metals, intestinal challenge in anesthetized rats, where either xyloglucan (XG) ischemia, allergies or intolerances). or a combination of xyloglucan (XG) and gelatin (P) were [0004] Acute diarrhoea due to infection is a serious prob orally administered 6 hrs before CT challenge. lem in developing countries as it is believed to cause the death [0015] FIG. 2 depicts the difference in water secretion in of at least 4 million children less than 5 years old annually. isolated intestinal jejunal loops 2 hrs after cholera toxin (CT) [0005] Chronic diarrhoea is most often caused by irritable challenge in anesthetized rats, where either gelatin (Gel) was bowel syndrome, coeliac disease, or inflammatory bowel dis orally administered 6 hrs before CT challenge, or a combina eases (e.g., Crohn’s disease, ulcerative colitis). tion of xyloglucan and gelatin (XG-Gel) was orally adminis [0006] In the light of the various etiologies, different thera tered 12 hrs before CT challenge. peutic options are available that are based on the administra tion of antibiotics/antibacterial agents, antispasmodic/anti DETAILED DESCRIPTION cholinergic agents, probiotics, and opioid receptor agonists. [0016] Surprisingly, it has now been found that combina Some of these treatments must however be used with great tions of xyloglucans with vegetable or animal proteins com caution as they do not act on the disease’s causal process. patible with oral administration in humans are particularly [0007] To overcome these negative effects, tannins com effective in the treatment and prevention of diarrhoea and plexed with animal proteins and gelatins, in particular with other infectious and/or inflammatory intestinal disorders. bovine gelatin, albumin, casein, and ovalbumin have long Xyloglucans are believed to have a film-forming effect on been proposed. intestinal mucosa that can decrease the permeability of the [0008] The use of such complexes in the treatment, for tight junctions of the intestinal mucosa and therefore impede example, of diarrhoea in its various forms is described in EP the entry of the pathogens responsible for acute intestinal 1764105, EP 2526939, EP 2361623 and US 20090062191. infections. The film-forming effect is not affected by pH Gelatin tannate has long been commercially available in cer changes. tain compositions or as a medical device for the treatment of [0017] In a principal embodiment the invention therefore acute diarrhoea. provides pharmaceutical compositions that have, as active [0009] Thus there arises the need for further therapeutic ingredients, xyloglucans or extracts that contain them incom treatments capable of replacing or being administered along bination with vegetable or animal proteins, in addition to side the ones available currently. suitable excipients, and other optional active ingredients. In an embodiment, the compositions are useful for the preven SUMMARY OF THE INVENTION tion and treatment of intestinal and genitourinary disorders. [0010] In one embodiment, the invention provides pharma [0018] Xyloglucans are molecules composed of a linear ceutical compositions comprising, as active ingredients, skeleton of fl-1,4-glucans with short lateral branches. These xyloglucans or xyloglucan-containing extracts and animal or branches can bind to one another (and other polar, hydrophilic vegetable proteins, combined with suitable excipients and molecules) due to xylose bonded to oxygen at the 6-position possibly with other active ingredients useful for the treatment of the sugar. These branched side chains may also contain of intestinal disorders, in particular diarrhoeal diseases. other sugars such as arabinose and fucose. US 2015/0094.266 A1 Apr. 2, 2015 [0019] Xyloglucans belong to the hemicellulose family ably between about 10 mg/dose and about 100 mg/dose. The associated with the cellulose within the cell wall of higher total daily dose of xyloglucan can be about 400 mg to about plants. A particularly rich source of xyloglucans is the seed of 800 mg. the tamarind (Tamarindus indica), a tropical tree native to [0029] The protein, in particular gelatin, may be adminis East Africa. tered orally at doses between about 10 mg/dose and about [0020) Extracts of tamarind seeds rich in xyloglucans are 3000 mg/dose, preferably between about 50 mg/dose and known and have been used in the medical field mainly as about 500 mg/dose. viscosifying agents in ophthalmic compositions or uses (U.S. [0030] The invention’s compositions are useful for the Pat. No. 6,056,950), mucoadhesive agents (WO2006/ treatment and prevention of intestinal disorders and in any 131262), tear substitutes (WO2009/044423), anti-infective case of disorders that originate in the intestinal system and are agents (WO2011/147767) and anti-inflammatory agents transferred to other systems, such as the genitourinary sys (WO2011/147768). tem. In fact, it is known that Gram-negative bacteria present [0021] The xyloglucans extracted from Tamarindus indica in the intestine, in particular Escherichia coli, can proliferate are commercially available, for example from Indena (Italy) in this organ
Load more

Recommended publications
  • Digestive System Student Lesson
    +NOW9OUR"ODY $)'%34)6%!.$%8#2%4/293934%-3 tableTABLE OF CONTENTS of contents Introduction ........................................................................................I Objectives ....................................................................................... VII Teaching Suggestions and Additional Activities ....................... VIII Research and Standards ................................................................ XI Digestive System Student Lesson ..............................................................................1 Activity Sheets ............................................................................... 7 Excretory System Student Lesson ............................................................................12 Activity Sheets ............................................................................. 18 Health Issues Student Lesson ............................................................................ 21 Activity Sheets ............................................................................. 26 Review Review Sheets ............................................................................. 29 Assessments Quizzes ........................................................................................ 36 Unit Test .......................................................................................43 Answer Key ..................................................................................... 50 introductionINTRODUCTION As growing and maturing individuals, adolescents
    [Show full text]
  • It Must Be Karma: the Story of Vicki Joy and Johnnymoon
    University of New Orleans ScholarWorks@UNO University of New Orleans Theses and Dissertations Dissertations and Theses 5-14-2010 It Must be Karma: The Story of Vicki Joy and Johnnymoon Richard Bolner University of New Orleans Follow this and additional works at: https://scholarworks.uno.edu/td Recommended Citation Bolner, Richard, "It Must be Karma: The Story of Vicki Joy and Johnnymoon" (2010). University of New Orleans Theses and Dissertations. 1121. https://scholarworks.uno.edu/td/1121 This Thesis is protected by copyright and/or related rights. It has been brought to you by ScholarWorks@UNO with permission from the rights-holder(s). You are free to use this Thesis in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights- holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/or on the work itself. This Thesis has been accepted for inclusion in University of New Orleans Theses and Dissertations by an authorized administrator of ScholarWorks@UNO. For more information, please contact [email protected]. It Must be Karma: The Story of Vicki Joy and Johnnymoon A Thesis Submitted to the Graduate Faculty of the University of New Orleans in partial fulfillment of the requirements for the degree Master of Fine Arts in Film, Theatre and Communication Arts Creative Writing by Rick Bolner B.S. University of New Orleans, 1982 May, 2010 Table of Contents Prologue ...............................................................................................................................1
    [Show full text]
  • Healing Irritable Bowel Syndrome with Diaphragmatic Breathing
    Biofeedback ÓAssociation for Applied Psychophysiology & Biofeedback Volume 45, Issue 4, pp. 83–87 www.aapb.org DOI: 10.5298/1081-5937-45.4.04 SPECIAL ISSUE Healing Irritable Bowel Syndrome with Diaphragmatic Breathing Erik Peper, PhD, Lauren Mason, and Cindy Huey San Francisco State University, San Francisco, CA Keywords: irritable bowel syndrome (IBS), diaphragmatic breathing, posture, biofeedback, self-healing Irritable bowel syndrome (IBS) affects 7 to 21% of the children is called recurrent abdominal pain (RAP), which general population and is a chronic condition. The affects 0.3% to 19% of schoolchildren (Chitkara, Rawat, & symptoms usually include abdominal cramping, discomfort Talley, 2005). Both IBS and RAP appear to be functional or pain, bloating, loose or frequent stools and constipation, illnesses because no organic causes have been identified to and can significantly reduce the quality of life. This case explain the symptoms. In the United States, this results report describes how a 22-year-old woman, who was annually in more than 3.1 million physician visits and 5.9 initially diagnosed with IBS when she was a high school million prescriptions. The total direct and indirect cost of junior, healed herself from IBS with slow abdominal these services exceeds $20 billion (Chey et al., 2015). breathing without any therapeutic coaching. She has Multiple factors may contribute to IBS, such as genetics, food allergies, previous treatment with antibiotics, severity continued to be symptom-free for the last three years. of infection, psychological status, and stress. More recently, The article reviews how slower diaphragmatic breathing changes in the intestinal and colonic microbiome resulting (abdominal breathing) may reduce symptoms of IBS, in small intestine bacterial overgrowth are suggested as explores the possibility that breathing is more than another risk factor (Dupont, 2014).
    [Show full text]
  • Symptom Evaluation of Long-Term Postoperative Outcomes After Pylorus-Preserving Gastrectomy for Early Gastric Cancer
    Gastric Cancer (2007) 10: 167–172 DOI 10.1007/s10120-007-0434-7 2007 by International and Japanese Gastric Cancer Associations Original article Symptom evaluation of long-term postoperative outcomes after pylorus-preserving gastrectomy for early gastric cancer SOUYA NUNOBE, MITSURU SASAKO, MAKOTO SAKA, TAKEO FUKAGAWA, HITOSHO KATAI, and TAKESHI SANO Department of Surgery, National Cancer Center Hospital, Tokyo 104-0045, Japan Abstract Introduction Background. Since the early 1990s, pylorus-preserving gas- trectomy (PPG) has been used in the treatment of patients The incidence of early gastric cancer has been increas- with early gastric cancer in order to reduce postprandial symp- ing for decades, reaching nearly 60% in Japan [1–4]. toms. To date, there have been few reports of long-term A conventional distal gastrectomy with lymph node symptom evaluation following this procedure. The aim of this dissection followed by Billroth-I -type reconstruction study was to evaluate long-term postoperative outcomes after PPG. (DGBI) has been the accepted procedure for early Methods. Three hundred and ninety-seven patients with early gastric cancer in the middle third of the stomach [5]. gastric cancer were enrolled in this study: 194 patients who While this treatment has achieved excellent survival, underwent PPG and 203 who underwent distal gastrectomy dumping syndrome, remnant gastritis, refl ux esophagi- with Billroth-I reconstruction (DGBI). We compared the tis, and impaired weight gain are common in patients symptoms for the two groups in a questionnaire on postopera- who have undergone DGBI [6]. tive functional outcomes, endoscopy fi ndings and the appear- The low probability of lymph node metastasis in these ance of gallstones after surgery.
    [Show full text]
  • Food for Thought: Digest of Digestion & Nutrition Rancho La Puerta
    Food for Thought: Digest of Digestion & Nutrition Rancho La Puerta Joseph Weiss, MD, FACP, FACG, AGAF Clinical Professor of Medicine, University of California, San Diego The purpose of the digestive tract is to support life by providing the nutrition and energy we need for all of our body functions. The average human has over 37 billion cells, with 25 million new cells created every second. Each existing cell requires energy to fulfill its metabolic function. All human cells, except for red blood cells, has mitochondria that serve as the equivalent of an energy power plant. It is believed that eons ago mitochondria were free living unicellular organisms, such as archaea or bacteria. In a process known as endosymbiosis, they became incorporated into human cells, where they serve a vital function. Perhaps as a residue of their previous independent lives, mitochondria carry their own DNA, inherited in a matrilineal pattern. The more metabolically active the cell, the more mitochondria it has. The liver cells, as well as nerve cells are some of the most active in the body, with each cell containing over 2,000 mitochondria in the cytoplasm. On average, a human cell has over one million chemical reactions occurring every second. The energy and nutrition needs of the human organism are enormous, and the digestive tract must provide for all of this and more, as it also supplies the gut microbiome with its needs. Perhaps the analogy is not the best one, but think of the digestive tract as the reverse of the assembly line, a disassembly line. A factory has a goal to be efficient and profitable, and may not win too many awards for architectural beauty.
    [Show full text]
  • Hyperactive Bowel Sounds Medical Term
    Hyperactive Bowel Sounds Medical Term Miffed Mose saiths loose. Elevated Freddie anguish her pelvis so idly that Witty group very evil-mindedly. Bigoted Edsel hocuses or bristles some bosket inexpertly, however siltiest Charles pitchforks parlando or escrow. Please consult your digestive activity and left lower abdomen much improvement is life threatening if you will discuss the conditions not be continued evaluation with hyperactive sounds are wrapped around Learn all terms and spoke with flashcards games and brilliant study tools. Gastrointestinal function in intensive care patients Terminology. Normal hyperactive bowel sounds medical term for beginning your stomach growls How minor must you listen until the abdomen before determining that bowel sounds. Lack of intestinal activity Many medical conditions may prevail to ileus. Unlike heart and respiratory rates abdominal sounds do cross punch a. Who just been fed it also occurs in term infants and infants who either never received. Eluxadoline Virbezi treats abdominal pain and diarrhea hallmark symptoms of. How to accommodate Stomach Growling Without Eating and enforce Night. Bsca may reveal diminished bowel in terms, awakens with surgery or requiring intubation for a hypokalemic, sounds may sound. Check your medical term diarrhoea. Adhesionsscar tissue remains behind your most cases by previous abdominal surgery. Using a stethoscope in clinical practice in major acute sector. Future improvements may ruin a long-term unsupervised expert system of multichannel bowel. Search for each topic using the Merriam Webster medical dictionary. Prompt medical care legal help with avoid potentially serious complications. Bowel sounds hypoactive or hyperactive in quadrant location. Doctors use free last definition although maybe sometimes use 3 when examining a toss In short if.
    [Show full text]
  • National Consensus on the Diagnosis, Treatment, Monitoring and Prevention of Hereditary Transthyretin Amyloidosis
    National Consensus on the Diagnosis, Treatment, Monitoring and Prevention of Hereditary Transthyretin Amyloidosis Editor: Prof. I. Milanov and Prof. I. Tournev, Sofia, 2019 On the initiative of: Bulgarian Association for Neuro-muscular Diseases Bulgarian Society of Neurology Bulgarian Society of Cardiology Bulgarian Society of Gastroenterology 0 Contents Abbreviations used:...........................……………………………………………………........4 Introduction........................................................................................................................5 Pathophysiology................................................................................................................6 Genetic Aspects..............................................................................................................10 Worldwide Epidemiology.................................................................................................12 Epidemiology for Bulgaria...............................................................................................13 Neurological Impairment.................................................................................................17 Cardiac Impairment.........................................................................................................23 Gastroenterological Impairment......................................................................................23 Diagnosing.......................................................................................................................25
    [Show full text]
  • Physiology News
    PHYSIOLOGY NEWS winter 2010 I number 78 A celebration of JZ Young Heart size and Prometheus’ giblets Is industrial experience useful? New initiatives for undergraduate physiologists New technology for physiology courses saves time, money and resources! Free up your lab for more sessions. ADInstruments has announced that LabTutor 4 with Our technology provides the opportunity to Server and Online components will be released on reduce lab session times without changing the March 1, 2010. This technology provides remarkable quality of learning, time and cost savings through: double student numbers without Remote student access to experiments doubling data Pre-lab preparation or post-lab data analysis acquisition systems and reporting, outside the lab. and eliminate printed Independent learning lab materials. Self-contained experiments that include background, objectives and instructions, real data acquisition, analysis and reports, all in one adinstruments.com/labtutor4preview easy-to-use interface. Centralised administration Follow this address to find out Single-point control for any number of courses, more and register for your preview. lab sessions, and networked locations. EQUIPMENT CERTIFIED FOR HUMAN CONNECTION UK • GERMANY • USA • BRAZIL • CHILE • INDIA • JAPAN • CHINA • MALAYSIA • NEW ZEALAND • AUSTRALIA LabTutor4PhysiologyAd280x200.indd 1 25/1/10 12:10:49 PM PHYSIOLOGY NEWS Editorial 3 The Society’s dog. ‘Rudolf Magnus Meetings gave me to Charles Sherrington, who Towards an understanding of the enteroendocrine system 4 gave me
    [Show full text]
  • Lactose Intolerance Quick Test CLINICAL TRIAL
    Lactose Intolerance Quick Test CLINICAL TRIAL Performance of the LACTOSE INTOLERANCE Quick Test in Diagnosis of Adult-Type Hypolactasia Among Dyspeptic Patients. Jointly Executed by: Biohit Oyj (Helsinki, Finland); Hospital X (City Y, Country Z) Research Team: First Name, Second Name, ..... ________________________________________________________________________________________________ LACTOSE INTOLERANCE Quick Test is the Registered trademark of Biohit Oyj (Helsinki, Finland). 2 Summary Background: Hypolactasia, or lactose intolerance (LI) exists in three different forms: i) primary (adult-type), ii) secondary, and iii) congenital. Adult-type hypolactasia, also known as lactose malabsorption or lactase non-persistence, is an autosomal recessive condition that affects about half of the world’s population. It is caused by the developmental down- regulation of the lactase-phlorizin hydrolase (LPH) enzyme in the brush border of epithelial cells in the small intestines. Affected persons have insufficient levels of lactase that catalyses hydrolysis of lactose into glucose and galactose in their digestive system. Consuming milk and other dairy products causes gastrointestinal symptoms which vary in severity and may include abdominal bloating and cramps, flatulence, diarrhoea, nausea, borborygmi (rumbling stomach), or vomiting. Similar dyspeptic symptoms can be caused by a wide variety of gastrointestinal disorders and diseases, and making a specific clinical diagnosis is essential to establish correct therapeutic measures. Biohit Oyj (Helsinki, Finland) has developed two diagnostic tests for patients with dyspeptic symptoms: 1) Biohit GastroPanel® test, and 2) Biohit LACTOSE INTOLERANCE Quick Test (LIQT), for assessment of 1) gastric mucosal structure and function, as well as 2) for rapid (POC; point- of-care) diagnosis of hypolactasia (LI), respectively. Clinical validation studies in different settings are advocated for both tests.
    [Show full text]
  • ACF-Digestion and GI Health 1
    Copyright © 2015 All rights reserved. Neither this document nor any part of it may be reproduced or transmitted in any form or by any means including photocopying, email, fax, etc. without prior written permission of the author. Advanced Clinical Focus: Digestion and GI Health presented by Josh Gitalis ADVANCED CLINICAL FOCUS DigestionAdvanced Clinical Focus: &Digestion GI Health and GI Health What you will learn... • The digestive process • IBS • The 5 R’s of digestive • Digestive healing diets healing • Therapeutic foods • Leaky gut syndrome • Autoimmune disease • Allergies • IBD Copyright © 2015 ● Josh Gitalis Ba(H), RNCP/ROHP, CNP ● All Rights Reserved ADVANCED CLINICAL FOCUS DigestionAdvanced Clinical Focus: &Digestion GI Health and GI Health What you will not learn... • Protocols • One-size-fits-all ADVANCED CLINICAL FOCUS DigestionAdvanced Clinical Focus: &Digestion GI Health and GI Health GI Facts • Largest surface area that interacts with the environment • Site where the needs of nutrient absorption and host defences collide ADVANCED CLINICAL FOCUS DigestionAdvanced Clinical Focus: &Digestion GI Health and GI Health GI Facts Copyright © 2015 ● Josh Gitalis Ba(H), RNCP/ROHP, CNP ● All Rights Reserved The Digestive Process ADVANCED CLINICAL FOCUS DigestionAdvanced Clinical Focus: &Digestion GI Health and GI Health The Digestive Process ADVANCED CLINICAL FOCUS DigestionAdvanced Clinical Focus: &Digestion GI Health and GI Health Complex Ecological Network • Proper pH • Microbiome • Smooth muscle tone • Lifestyle • Stomach acid • Pancreatic
    [Show full text]
  • Potato Fibers Have Positive Effects on Subjective Appetite
    nutrients Article Potato Fibers Have Positive Effects on Subjective Appetite Sensations in Healthy Men, but Not on Fecal Fat Excretion: A Randomized Controlled Single-Blind Crossover Trial Tanja Kongerslev Thorning y, Christel Johanneson Bertolt y, Mette S. Nielsen *, Christian Ritz , Arne Astrup and Anne Raben Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, 1958 Frederiksberg C, Denmark; [email protected] (T.K.T.); [email protected] (C.J.B.); [email protected] (C.R.); [email protected] (A.A.); [email protected] (A.R.) * Correspondence: [email protected]; Tel.: +45-35331012 These authors contributed equally to this work. y Received: 13 October 2020; Accepted: 11 November 2020; Published: 13 November 2020 Abstract: Dietary fibers can affect appetite and gut metabolism, but the effect of the novel potato fibers FiberBind and rhamnogalacturonan I (RG-I) is unknown. We, therefore, aimed to investigate the effect of daily intake of FiberBind and RG-I on appetite sensations and fecal fat excretion. In a single-blinded, randomized, three-way crossover trial, wheat buns with FiberBind, RG-I, or low fiber (control) were consumed by 18 healthy men during a 21-day period. Appetite sensation and blood samples during a 3 h meal test, fecal fat content, and ad libitum energy intake were assessed after each period. Compared to RG-I and control, FiberBind caused a higher composite satiety score (6% 2% and 5% 2%), lower prospective food consumption (5% 2% and 6% 2%), and lower ± ± ± ± desire to eat (7% 3% and 6% 3%) (all p < 0.05).
    [Show full text]
  • Detection of Bowel Sounds
    Detection of Bowel Sounds Kaja Kvello Master of Science in Cybernetics and Robotics Submission date: June 2018 Supervisor: Øyvind Stavdahl, ITK Co-supervisor: Konstanze Kölle, ITK Anders Lyngvi Fougner, ITK Norwegian University of Science and Technology Department of Engineering Cybernetics Abstract This thesis describes the development and implementation of a bowel sound detection algorithm, which ultimately might be used as part of a meal detection system in an arti- ficial pancreas. An artificial pancreas is an advanced blood glucose regulation system for patients with diabetes. In order to correctly provide insulin doses to the user, artificial pan- creases need to detect when the patient is eating. One possible approach for meal detection is monitoring bowel sound occurrence frequency. This further necessitates a bowel sound detection system, such as the one described in this thesis. The detection algorithm will consist of a combination of signal processing techniques for feature extraction, and pattern recognition in order to classify sound segments as either bowel sound segments or non-bowel sound segments. A linear support vector machine was chosen for classification in the final solution. The Python implementation of the detection system yielded promising results on a provided data set of sound measurements from the stomach. However, certain improvements and refinements should be done to the system before potential integration into an artificial pancreas. The thesis also briefly discusses these further development needs. Chapter1 explains the motivation behind the assignment, as well as the problem descrip- tion and approach. Chapter2 provides the most important theoretical background for the work described in this thesis. Chapters3 and4 describe the method and work towards the final product.
    [Show full text]